Passage BIO, Inc. current report, 15 December 2020

Passage Bio, Inc. — Form 8-K Summary

Business Context and Reporting Period

Passage Bio filed a current report dated December 15, 2020, reporting entry into a material lease agreement. The company is a Delaware corporation whose common stock trades on the Nasdaq Global Select Market under the symbol PASG.

Material Agreement and Financial Impact

  • Property: Approximately 62,000 square feet at 311 Pennington Rocky Hill Road, Hopewell, New Jersey.
  • Planned use: A new chemistry, manufacturing and controls laboratory.
  • Lease term: 15 years beginning on the later of March 15, 2021, or the date the landlord delivers the property in sufficient condition.
  • Renewal options: Up to two additional five-year terms.
  • Rent: Initial annual rent of approximately $1.5 million, after partial rent abatement for the first year.
  • Total initial-term rent: Approximately $40.3 million.
  • Security deposit: None required.

Changes Versus the Prior Comparable Period

The filing text does not provide comparative financial statements or prior-period operating results. The material change disclosed is the company’s commitment to a long-term lease for a new manufacturing-related laboratory facility.

Guidance, Outlook, Risks and Unusual Items

Management expects the premises to support the company’s chemistry, manufacturing and controls activities. The lease creates a substantial long-term occupancy commitment, with commencement dependent on timely property delivery. The filing does not provide revenue guidance, profitability guidance, cash-flow guidance, or a broader business outlook.

Investor Verification Items

  • Verify the final lease commencement date and delivery condition of the premises.
  • Review the complete lease, including omitted schedules and exhibits, for escalation clauses, tenant-improvement obligations, operating expenses, termination rights and renewal economics.
  • Assess the accounting treatment and balance-sheet impact of the lease in subsequent financial statements.
  • Evaluate whether construction, permitting, delivery or operational delays could affect the planned laboratory timeline.
  • Review future filings for cash requirements and liquidity implications from the approximately $40.3 million initial-term rent commitment.